The Washington Times

Cleveland Clinic

Latest Cleveland Clinic Items
  • Cavs' Varejao done for season with blood clot

    Anderson Varejao's season rapidly spiraled from a probable All-Star appearance to over.


  • LinkedIn links up with panel of 'influencers'

    LinkedIn is adding more expert advice to its website and making it easier for its users to find their pearls of wisdom.


  • Is ur #MD 2 square? Some use e-tech with patients

    Is your doctor a technophobe? Increasingly, the answer may be no. There's a stereotype that says doctors shun technology that might threaten patients' privacy and their own pocketbooks. But a new breed of physicians is texting health messages to patients, tracking disease trends on Twitter, identifying medical problems on Facebook pages and communicating with patients through email.


  • Browns DE Benard feels "blessed" after accident

    As sweat beads streaked his cheeks, defensive end Marcus Benard looked out at the green practice fields behind the Browns' training facility.


  • Studies: Surgery can put diabetes into remission

    New research gives clear proof that weight-loss surgery can reverse and possibly cure diabetes, and doctors say the operation should be offered sooner to more people with the disease _ not just as a last resort.


  • Surgery can put Type 2 diabetes into remission

    New research gives clear proof that weight-loss surgery can reverse and possibly cure diabetes, and doctors say the operation should be offered sooner to more people with the disease _ not just as a last resort.


  • FDA panel backs Glaxo drug for rare sarcoma cancer

    A panel of cancer experts rejected an experimental Merck drug for a rare form of cancer on Tuesday while recommending approval of a GlaxoSmithKline treatment for the same disease. Neither drug appears to help patients live longer, but panelists said Glaxo's Votrient helped delay tumor growth in the most vulnerable patients.


  • FDA panel backs Glaxo drug for rare cancer

    A panel of cancer experts rejected an experimental Merck drug for a rare form of cancer on Tuesday while recommending approval of a GlaxoSmithKline treatment for the same disease. Neither drug appears to help patients live longer, but panelists said Glaxo's Votrient helped delay tumor growth in the most vulnerable patients.


  • Cavs Irving out next 2 games with concussion

    Cavaliers rookie guard Kyrie Irving will spend the weekend resting and recovering from his concussion.


Happening Now